Pathogenic Fungi: Systemic and Opportunistic Mycoses

Pathogenic Fungi

Overview of Systemic Mycoses

Systemic mycoses are fungal infections that affect internal organs and are often acquired through inhalation. Four major genera—Histoplasma, Blastomyces, Coccidioides, and Paracoccidioides—are responsible for these diseases. All are dimorphic fungi, meaning they grow as mycelial thalli in the environment and as spherical yeasts in the human body.

• Dimorphism: Environmental form (hyphae and spores) vs. human form (budding yeast cells).

• Transmission: Inhalation of spores is the primary route.

• Pathogenesis: Begins as pulmonary infection, can disseminate via blood.

Histoplasmosis

Histoplasma capsulatum is the most common fungal pathogen affecting humans. It thrives in moist soils with high nitrogen content and is acquired mainly by inhaling spores. Once in the lungs, the fungus is phagocytized by macrophages and can spread via blood and lymph.

• Clinical Manifestations: Usually asymptomatic; four main disease types: chronic pulmonary, chronic cutaneous, systemic, and ocular histoplasmosis.

• Diagnosis: Identification of yeast in patient samples.

• Treatment: Amphotericin B or ketoconazole for severe cases.

Blastomycosis

Blastomyces dermatitidis causes blastomycosis, found in soils rich in organic matter. Pulmonary blastomycosis is the most common manifestation, often asymptomatic but can become chronic. The fungus can also cause cutaneous, osteoarticular, and CNS infections.

• Diagnosis: Identification of fungi in culture or samples.

• Treatment: Oral itraconazole or amphotericin B; relapse common in AIDS patients.

Coccidioidomycosis (Valley Fever)

Coccidioides immitis is found in desert soils of the southwestern US and northern Mexico. Infection rates have risen due to population expansion and increased recreational activities. Inhaled arthroconidia germinate into spherules in the lung, releasing spores.

• Clinical Manifestations: Pulmonary conditions, often asymptomatic; serious infections in immunocompromised individuals.

• Diagnosis: Presence of spherules in patient samples or positive skin test.

• Treatment: Amphotericin B; maintenance therapy for AIDS patients.

Paracoccidioidomycosis

Paracoccidioides brasiliensis is found in southern Mexico and South America, mainly affecting farm workers. The infection begins as a pulmonary condition and can spread to create lesions. Diagnosis is based on the presence of yeast in a "steering wheel" formation.

• Treatment: Itraconazole, ketoconazole, or amphotericin B.

Opportunistic Fungal Pathogens

Overview

Opportunistic mycoses primarily affect individuals with compromised immunity or disrupted microbiomes. The five most common opportunists are Pneumocystis, Candida, Aspergillus, Cryptococcus, and Mucor.

• Risk Factors: AIDS, cancer, diabetes, immunosuppressive therapy.

• Diagnosis: Often challenging due to atypical symptoms.

Pneumocystis Pneumonia

Pneumocystis jirovecii is a common opportunistic infection in AIDS patients, almost diagnostic for AIDS. Transmission is likely via inhalation, and most people are exposed by age five. Infection in immunocompetent individuals is usually asymptomatic.

• Diagnosis: Clinical and microscopic findings.

• Treatment: Trimethoprim and sulfamethoxazole.

Aspergillosis

Diseases caused by Aspergillus species result from inhalation of spores. Three clinical pulmonary diseases may develop: hypersensitivity (asthma/allergy), noninvasive (fungal masses in lung cavities), and acute invasive (pneumonia).

• Diagnosis: Clinical history, abnormal lung structure, identification of septate hyphae and conidia in samples.

• Treatment: Allergy medications for hypersensitivity; surgical removal and intravenous voriconazole for invasive disease; itraconazole for maintenance in AIDS patients.

Cryptococcosis

Cryptococcus neoformans causes cryptococcosis, with two varieties: C. neoformans gattii (immunocompetent) and C. neoformans neoformans (AIDS patients). Infection results from inhalation of spores or dried yeast in bird droppings. The fungus resists phagocytosis and has a predilection for the CNS.

• Clinical Manifestations: Pulmonary, meningitis, cryptococcoma, cutaneous forms.

• Diagnosis: Identification of fungus in patient samples.

• Treatment: Amphotericin B and 5-fluorocytosine; fluconazole for maintenance.

Mucormycosis and Microsporidiosis

Mucormycosis is caused by Mucor species, common in the environment. Infections develop in the face and head, especially in diabetics, cancer patients, and drug users. Microsporidiosis is caused by obligate intracellular fungi, including Microsporidium, Encephalitozoon, and Nosema.

• Mucormycosis: Can cause rhinocerebral, pulmonary, gastrointestinal, cutaneous infections. Diagnosis is by microscopy; treatment is removal of infected tissue and amphotericin B.

• Microsporidiosis: Primarily affects immunocompromised; severe diarrhea is common. Diagnosed by microscopy, TEM, immunoassays, PCR; treated with albendazole.

Fungal Pathogens in Covid-19 Patients

Opportunistic Fungi in Covid-19

Patients with severe Covid-19 are vulnerable to opportunistic fungal infections, especially pulmonary aspergillosis and invasive candidiasis. Early diagnosis and treatment are critical.

• Diagnosis: CAPA involves lower respiratory tract specimens and testing for Aspergillus galactomannan antigen; candidemia diagnosed by symptoms and fungal culture.

• Treatment: Early intervention is essential.

Clinical Manifestations of Candidiasis

Table: Types, Symptoms, and Predisposing Factors

Candidiasis presents in various forms, each with distinct clinical signs and predisposing factors. The following table summarizes these manifestations:

Type	Clinical Signs and Symptoms	Predisposing Factors
Oropharyngeal (thrush)	White plaques on mouth, tongue, gums, palate, pharynx	Diabetes, AIDS, cancers, chemotherapy
Cutaneous	Moist red rash between skin folds, diaper rash, onychomycosis	Moisture, heat, friction, obesity, immunocompromised
Vulvovaginal	Creamy discharge, burning, redness, painful intercourse	Antibiotics, pregnancy, diabetes, microbiome changes
Chronic mucocutaneous	Lesions on skin, nails, mucous membranes	Impaired cell-mediated immunity
Neonatal and congenital	Meningitis, renal disorders, generalized rash	Young age, low birth weight, maternal antibiotics
Esophageal	White plaques, burning pain, nausea, vomiting	AIDS, immunocompromised
Gastrointestinal	Ulceration of stomach and intestinal mucosa	Hematological cancers
Pulmonary	Nonspecific symptoms, often undiagnosed	Spread from other candidiasis types
Peritoneal	Fever, pain, tenderness	Dialysis catheters, GI perforation
Urinary tract	Painful urination, discharge	Catheterization, diabetes, bladder problems
Meningeal	Swelling, fever, headache, neck stiffness	Systemic spread
Renal	Fever, pain, fungus ball	Additional info: Often associated with systemic infection
Hepatic and splenic	Fever, swelling, dysfunction, lesions	Leukemia
Endocardial, myocardial, pericardial	Fever, murmur, heart failure, anemia	Valve disease, catheterization, IV drug abuse
Ocular	Cloudy vision, eye lesions	Spread, catheters, IV drug abuse, trauma
Osteoarticular	Pain on weight-bearing	Spread, prosthetic implants
Candidemia	Antibiotic-resistant fever, tachycardia, hypotension, skin lesions, organ abscesses	Catheters, antibacterial drugs, surgery, burns

Laboratory Diagnosis and Media

Preferred Media for Fungal Culture

Saroubaud dextrose agar is the preferred medium for culturing fungi due to its ability to support fungal growth while inhibiting bacterial contamination.

Techniques for Detecting Fungal Cells in Tissues

Both KOH preparation and GMS staining are effective techniques for revealing the presence of fungal cells in tissues. KOH dissolves host tissue, making fungal elements more visible, while GMS stains fungal cell walls.

Summary

This guide covers the major systemic and opportunistic fungal pathogens, their clinical manifestations, diagnosis, treatment, and laboratory techniques. Understanding these concepts is essential for recognizing and managing fungal diseases in clinical practice.